Skip to main content

Advertisement

Log in

Leukocytic dysregulation in children with type 1 diabetes: relation to diabetic vascular complications

  • Original Article
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

Background

Growing evidences highlight the role of the innate immune response in the pathogenesis of type 1 diabetes (T1D) vascular complications. Neutrophil lymphocytic ratio (NLR) and platelet lymphocytic ratio (PLR) are inexpensive but novel markers of chronic inflammation might have prognostic value in children with T1D.

Aim

To study NLR and PLR levels in children with T1D in comparison to matched controls and correlate them with fraction-C of glycosylated hemoglobin (HbA1C) and micro-vascular complications.

Methodology

Hundred children with T1D were compared to 100 matched healthy controls. History included diabetes duration, insulin dose and frequency of hypoglycemic attacks. Fundus examination and the simple rapid neuropathy disability score were done. HbA1C, fasting lipids, urinary albumin excretion and complete blood count were measured with assessment of NLR and PLR

Results

NLR was significantly higher (p = 0.008) and PLR was significantly lower (p = 0.007) in children with T1D than controls. NLR was positively correlated while PLR was negatively correlated with HbA1C, diabetes duration, fasting cholesterol, triglycerides and LDL. NLR was significantly higher (p < 0.001) and PLR was significantly lower (p = 0.005) in children with microvascular complications than those without. Moreover, multivariate logistic regression revealed that microvascular complications were independently associated with NLR (p = 0.013) and PLR (p = 0.004).

Conclusion

Children with T1D had significantly higher NLR and lower PLR compared to controls. These changes were more evident in those with diabetic microvascular complications than those without. Furthermore, NLR was positively correlated and PLR was negatively correlated to HbA1C, diabetes duration and hyperlipidemia. Hence, NLR and PLR can be a potential indicator for the risk of development of diabetic microvascular complications in children with T1D.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Availability of data and material

Data will be available upon request.

Code availability

N/A.

Abbreviations

CRP:

C-reactive protein

HbA1C:

Fraction C of glycated hemoglobin

NDS:

Bedside neuropathy disability score

NLR:

Neutrophil–lymphocyte count ratio

PLR:

Platelet–lymphocyte count ratio

SMBG:

Self-monitoring of blood glucose

T1D:

Type 1 diabetes

T2D:

Type 2 diabetes

UAER:

Urinary albumin excretion ratio

References

  1. Gliwiński M, Iwaszkiewicz-Grześ D, Wołoszyn-Durkiewicz A, Tarnowska M, Żalińska M, Hennig M, Zielińska H, Dukat-Mazurek A, Zielkowska-Dębska J, Zieliński M, Jaźwińska-Curyłło A, Owczuk R, Jarosz-Chobot P, Bossowski A, Szadkowska A, Młynarski W, Marek-Trzonkowska N, Moszkowska G, Siebert J, Myśliwiec M, Trzonkowski P. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy. BMJ Open Diabetes Res Care. 2020;8:e000873. https://doi.org/10.1136/bmjdrc-2019-000873.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Graves L, Donaghue K. Vascular complication in adolescents with diabetes mellitus. Front Endocrinol. 2020;11:340. https://doi.org/10.3389/fendo.2020.00370.

    Article  Google Scholar 

  3. Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol. 2021;20:9. https://doi.org/10.1186/s12933-020-01200-7.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mendes B, Oliveira A, Alcântara K. Comparison of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in normoglycemic and hyperglycemic subjects. Einstein (Sao Paulo). 2019;17(1):eAO4403. https://doi.org/10.31744/einstein_journal/2019AO4403.

    Article  Google Scholar 

  5. Oguntibeju O. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):45–63.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Paolisso P, Foà A, Bergamaschi L, Donati F, Fabrizio M, Chiti C, Angeli F, Toniolo S, Stefanizzi A, Armillotta M, Rucci P, Iannopollo G, Casella G, Marrozzini C, Galiè N, Pizzi C. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovasc Diabetol. 2021;20(1):33. https://doi.org/10.1186/s12933-021-01222-9.PMID:33530978;PMCID:PMC7856791.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Yang M, Weng H, Pei Q, Jing F, Yi Q. The relationship between retinol-binding protein 4 and markers of inflammation and thrombogenesis in children with Kawasaki disease. Mediators Inflamm. 2021;11(2021):7029514. https://doi.org/10.1155/2021/7029514.PMID:33505217;PMCID:PMC7814943.

    Article  Google Scholar 

  8. Pian G, Li H, Piao Y. Clinical significance of inflammation markers in predicting the severity of acute pancreatitis. Pancreas. 2021;50(2):201–5. https://doi.org/10.1097/MPA.0000000000001749 (PMID: 33565796).

    Article  CAS  PubMed  Google Scholar 

  9. Liu J, Liu X, Li Y, Quan J, Wei S, An S, Yang R, Liu J. The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis. Biosci Rep. 2018;38(3):BSR20180172. https://doi.org/10.1042/BSR20180172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Forget P, Khalifa C, Defour J, Latinne D, Van Pel M, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12.

  11. Lee J, Kim N, Na S, Youn Y, Shin C. Reference values of neutrophil–lymphocyte ratio, lymphocytemonocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine. 2018;97(26):e11138.

    Article  Google Scholar 

  12. Duman T, Aktas G, Atak B, Kocak M, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602–6. https://doi.org/10.4314/ahs.v19i1.35.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hasan K, Mustari M, Asaduzzaman M, Gaffar A, Chanda P, Rahman M, Hannan M, Akter F, Saifudddin M, Selim S. Evaluation of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as markers of diabetic kidney disease in Bangladeshi patients with type 2 diabetes mellitus. J Diabetol. 2020;12:58–62. https://doi.org/10.4103/jod.jod_4_20.

    Article  Google Scholar 

  14. Wang J, Chen Z, Yang K, Yang H, Tao W, Li Y, Jiang Z, Bai C, Yin Y, Duan J, Zhou Y, Geng X, Yang Y. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 2020;12:55. https://doi.org/10.1186/s13098-020-00562-y.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Liu W, Lin S, Wang L, Fang C, Lin Y, Braddock M, Zhu G, Zhang Z, Zheng M, Shen F. Platelet-to-lymphocyte ratio: a novel prognostic factor for prediction of 90-day outcomes in critically ill patients with diabetic ketoacidosis. Medicine. 2016;95(4):1–7.

    CAS  Google Scholar 

  16. Ilhan C, Citirik M, Uzel MM, Kiziltoprak H, Tekin K. The usefulness of systemic inflammatory markers as diagnostic indicators of the pathogenesis of diabetic macular edema. Arq Bras Oftalmol. 2020;83(4):299–304. https://doi.org/10.5935/0004-2749.20200051 (Epub 2020 Jul 29 PMID: 32756784).

    Article  PubMed  Google Scholar 

  17. Tsalamandris S, Antonopoulos A, Oikonomou E, Papamikroulis G, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol Rev. 2019;14(1):50–9. https://doi.org/10.15420/ecr.2018.33.1.

    Article  Google Scholar 

  18. Baghersalimi A, Koohmanaee S, Darbandi B, Farzamfard V, Hassanzadeh Rad A, Zare R, Tabrizi M, Dalili S. Platelet indices alterations in children with type 1 diabetes mellitus. J Pediatr Hematol Oncol. 2019;41(4):e227–32. https://doi.org/10.1097/MPH.0000000000001454.

    Article  PubMed  Google Scholar 

  19. Herrera B, Rosas X, Pérez M, Castañeda M, Paulín L, Díaz R. Comparison of neutrophil/lymphocyte ratio according to degree of glycemic control in children with recent-onset type 1 and type 2 diabetes. ESPE Abstr. 2016;86:P-P2-274.

    Google Scholar 

  20. Mayer-Davis E, Kahkoska A, Jefferies C, Dabelea D, Balde N, Gong C, Craig M. ISPAD clinical practice consensus guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19:7–19.

    Article  Google Scholar 

  21. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5. https://doi.org/10.1186/1471-2288-5-13

  22. Hozo S, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2015;5:13. https://doi.org/10.1186/1471-2288-5-13.

    Article  Google Scholar 

  23. Bolster NM, Bastawrous A. Chapter 25: Examining the optic fundus and assessing visual acuity and visual fields using mobile technology. Revolutionizing Tropical Medicine: Point-of-Care Tests, New Imaging Technologies and Digital Health. Wiley; 2019.

  24. Yang Z, Chen R, Zhang Y, Huang Y, Hong T, Sun F, Ji L, Zhan. Scoring systems to screen for diabetic peripheral neuropathy Cochrane Database Syst Rev. 2014;2018(7):CD010974.

  25. Balder J, Lansberg P, Hof M, Wiegman A, Hutten B, Kuivenhoven J. Pediatric lipid reference values in the general population: the Dutch lifelines cohort study. J Clin Lipidol. 2018;12(5):1208–16. https://doi.org/10.1016/j.jacl.2018.05.011.

    Article  CAS  PubMed  Google Scholar 

  26. Goldstein D, Little R, Wie-dmeyer H, England J, McKenzie E. Glycated hemoglobin: methodologies and clinical applications. Clin Chem. 1986;32(10):B64-70.

    CAS  PubMed  Google Scholar 

  27. Viberti G, Hill R, Jarrett R, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1(8287):1430–2.

    Article  CAS  Google Scholar 

  28. Xu T, Weng Z, Pei C, Yu S, Chen Y, Guo W, Wang X, Luo P, Sun J. The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in type 2 diabetes mellitus. Medicine. 2017;96(45):e8289. https://doi.org/10.1097/MD.0000000000008289.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Hussain M, Babar M, Akhtar L, Hussain M. Neutrophil lymphocyte ratio (NLR): a well assessment tool of glycemic control in type 2 diabetic patients. Pak J Med Sci. 2017;33(6):1366–70. https://doi.org/10.12669/pjms.336.12900.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Luo W, Zhang W. The relationship of blood cell-associated inflammatory indices and diabetic retinopathy: a meta-analysis and systematic review. Int J Ophthalmol. 2019;12(2):312–23. https://doi.org/10.18240/ijo.2019.02.20.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Ayhan H, Kasapkara HA, Aslan AN, Durmaz T, Keleş T, Akçay M, Akar Bayram N, Baştuğ S, Bilen E, Sarı C, Bozkurt E. Relationship of neutrophil-to-lymphocyte ratio with aortic stiffness in type 1 diabetes mellitus. Can J Diabetes. 2015;39(4):317–21. https://doi.org/10.1016/j.jcjd.2015.01.004 (Epub 2015 Mar 19 PMID: 25797110).

    Article  PubMed  Google Scholar 

  32. Yu Y, Lin Q, Ye D, Wang Y, He B, Li Y, Huang G, Zhou Z, Xiao Y. Neutrophil count as a reliable marker for diabetic kidney disease in autoimmune diabetes. BMC Endocr Disord. 2020;20(1):158. https://doi.org/10.1186/s12902-020-00597-2.PMID:33092580;PMCID:PMC7580021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Devamsh N, Parvathi M, Madhumathi R, Leela R. Study of neutrophil lymphocyte ratio in patients with type 2 diabetes mellitus and its correlation with glycemic control. Int J Adv Med. 2019;6:1637. https://doi.org/10.18203/2349-3933.ijam20194233.

    Article  Google Scholar 

  34. Liu N, Sheng J, Pan T, Wang Y. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with lower extremity vascular lesions in chinese patients with type 2 diabetes. Clin Lab. 2019. https://doi.org/10.7754/Clin.Lab.2018.180804.

    Article  PubMed  Google Scholar 

  35. Fawwad A, Butt AM, Siddiqui IA, Khalid M, Sabir R, Basit A. Neutrophil-to-lymphocyte ratio and microvascular complications in subjects with type 2 diabetes: Pakistan’s perspective. Turk J Med Sci. 2018;48(1):157–61. https://doi.org/10.3906/sag-1706-141 (PMID: 29479977).

    Article  CAS  PubMed  Google Scholar 

  36. Jaaban M, Zetoune A, Hesenow S, Hessenow R. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021;7(7):e07564. https://doi.org/10.1016/j.heliyon.2021.e07564.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No funding was received.

Author information

Authors and Affiliations

Authors

Contributions

NS: conceptualization; data curation; formal analysis investigation; software; supervision; validation; visualization; roles/writing—original draft; NR: writing—review and editing, project administration; resources. HA: methodology; project administration; resources; writing—review and editing.

Corresponding author

Correspondence to Nouran Yousef Salah.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

The study was approved by the Research Ethics Committee of Ain-Shams University with an approval number R 27/2021.

Consent to participate

Informed consent was obtained from all patients for being included in the study.

Consent for publication

All authors have approved the manuscript for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salah, N.Y., Radwan, N. & Atif, H.M. Leukocytic dysregulation in children with type 1 diabetes: relation to diabetic vascular complications. Diabetol Int 13, 538–547 (2022). https://doi.org/10.1007/s13340-021-00568-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-021-00568-5

Keywords

Navigation